To require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks, and for other purposes.
About This Bill
Committee
Latest Action · June 13, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.